Expression profile of FcγRIIb on leukocytes and its dysregulation in systemic lupus erythematosus

Kaihong Su, Hengxuan Yang, Xinrui Li, Xiaoli Li, Andrew W. Gibson, John M. Cafardi, Tong Zhou, Jeffrey C. Edberg, Robert P. Kimberly

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

FcγRIIb (CD32B, Online Mendelian Inheritance in Man 604590), an IgG FcR with a tyrosine-based inhibitory motif, plays a critical role in the balance of tolerance and autoimmunnity in murine models. However, the high degree of homology between FcγRIIb and FcγRIIa in humans and the lack of specific Abs to differentiate them have hampered study of the normal expression profile of FcγRIIb and its potential dysregulation in autoimmune diseases such as systemic lupus erythematosus (SLE). Using our newly developed anti-FcγRIIb mAb 4F5 which does not react with FcγRIIa, we found that FcγRIIb is expressed on the cell surface of circulating B lymphocytes, monocytes, neutrophils, myeloid dendritic cells (DCs), and at very low levels on plasmacytoid DCs from some donors. Normal donors with the less frequent 2B.4 promoter haplotype have higher FcγRIIb expression on monocytes, neutrophils, and myeloid DCs similar to that reported for B lymphocytes, indicating that FcγRIIb expression on both myeloid and lymphoid cells is regulated by the naturally occurring regulatory single nucleotide polymorphisms in the FCGR2B promoter. FcγRIIb expression in normal controls is up-regulated on memory B lymphocytes compared with naive B lymphocytes. In contrast, in active SLE, FcγRIIb is significantly down-regulated on both memory and plasma B lymphocytes compared with naive and memory/plasma B lymphocytes from normals. Similar down-regulation of FcγRIIb on myeloid-lineage cells in SLE was not seen. Our studies demonstrate the constitutive regulation of FcγRIIb by natural gene polymorphisms and the acquired dysregulation in SLE autoimmunity, which may identify opportunities for using this receptor as a therapeutic target.

Original languageEnglish (US)
Pages (from-to)3272-3280
Number of pages9
JournalJournal of Immunology
Volume178
Issue number5
StatePublished - Mar 1 2007

Fingerprint

Systemic Lupus Erythematosus
Leukocytes
B-Lymphocytes
Myeloid Cells
Dendritic Cells
Monocytes
Neutrophils
Genetic Databases
Autoimmunity
Haplotypes
Autoimmune Diseases
Single Nucleotide Polymorphism
Tyrosine
Down-Regulation
Immunoglobulin G
Lymphocytes
Genes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Su, K., Yang, H., Li, X., Li, X., Gibson, A. W., Cafardi, J. M., ... Kimberly, R. P. (2007). Expression profile of FcγRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. Journal of Immunology, 178(5), 3272-3280.

Expression profile of FcγRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. / Su, Kaihong; Yang, Hengxuan; Li, Xinrui; Li, Xiaoli; Gibson, Andrew W.; Cafardi, John M.; Zhou, Tong; Edberg, Jeffrey C.; Kimberly, Robert P.

In: Journal of Immunology, Vol. 178, No. 5, 01.03.2007, p. 3272-3280.

Research output: Contribution to journalArticle

Su, K, Yang, H, Li, X, Li, X, Gibson, AW, Cafardi, JM, Zhou, T, Edberg, JC & Kimberly, RP 2007, 'Expression profile of FcγRIIb on leukocytes and its dysregulation in systemic lupus erythematosus', Journal of Immunology, vol. 178, no. 5, pp. 3272-3280.
Su K, Yang H, Li X, Li X, Gibson AW, Cafardi JM et al. Expression profile of FcγRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. Journal of Immunology. 2007 Mar 1;178(5):3272-3280.
Su, Kaihong ; Yang, Hengxuan ; Li, Xinrui ; Li, Xiaoli ; Gibson, Andrew W. ; Cafardi, John M. ; Zhou, Tong ; Edberg, Jeffrey C. ; Kimberly, Robert P. / Expression profile of FcγRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. In: Journal of Immunology. 2007 ; Vol. 178, No. 5. pp. 3272-3280.
@article{0b64a1e34cdb450b9c4b828b2ca5bcea,
title = "Expression profile of FcγRIIb on leukocytes and its dysregulation in systemic lupus erythematosus",
abstract = "FcγRIIb (CD32B, Online Mendelian Inheritance in Man 604590), an IgG FcR with a tyrosine-based inhibitory motif, plays a critical role in the balance of tolerance and autoimmunnity in murine models. However, the high degree of homology between FcγRIIb and FcγRIIa in humans and the lack of specific Abs to differentiate them have hampered study of the normal expression profile of FcγRIIb and its potential dysregulation in autoimmune diseases such as systemic lupus erythematosus (SLE). Using our newly developed anti-FcγRIIb mAb 4F5 which does not react with FcγRIIa, we found that FcγRIIb is expressed on the cell surface of circulating B lymphocytes, monocytes, neutrophils, myeloid dendritic cells (DCs), and at very low levels on plasmacytoid DCs from some donors. Normal donors with the less frequent 2B.4 promoter haplotype have higher FcγRIIb expression on monocytes, neutrophils, and myeloid DCs similar to that reported for B lymphocytes, indicating that FcγRIIb expression on both myeloid and lymphoid cells is regulated by the naturally occurring regulatory single nucleotide polymorphisms in the FCGR2B promoter. FcγRIIb expression in normal controls is up-regulated on memory B lymphocytes compared with naive B lymphocytes. In contrast, in active SLE, FcγRIIb is significantly down-regulated on both memory and plasma B lymphocytes compared with naive and memory/plasma B lymphocytes from normals. Similar down-regulation of FcγRIIb on myeloid-lineage cells in SLE was not seen. Our studies demonstrate the constitutive regulation of FcγRIIb by natural gene polymorphisms and the acquired dysregulation in SLE autoimmunity, which may identify opportunities for using this receptor as a therapeutic target.",
author = "Kaihong Su and Hengxuan Yang and Xinrui Li and Xiaoli Li and Gibson, {Andrew W.} and Cafardi, {John M.} and Tong Zhou and Edberg, {Jeffrey C.} and Kimberly, {Robert P.}",
year = "2007",
month = "3",
day = "1",
language = "English (US)",
volume = "178",
pages = "3272--3280",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "5",

}

TY - JOUR

T1 - Expression profile of FcγRIIb on leukocytes and its dysregulation in systemic lupus erythematosus

AU - Su, Kaihong

AU - Yang, Hengxuan

AU - Li, Xinrui

AU - Li, Xiaoli

AU - Gibson, Andrew W.

AU - Cafardi, John M.

AU - Zhou, Tong

AU - Edberg, Jeffrey C.

AU - Kimberly, Robert P.

PY - 2007/3/1

Y1 - 2007/3/1

N2 - FcγRIIb (CD32B, Online Mendelian Inheritance in Man 604590), an IgG FcR with a tyrosine-based inhibitory motif, plays a critical role in the balance of tolerance and autoimmunnity in murine models. However, the high degree of homology between FcγRIIb and FcγRIIa in humans and the lack of specific Abs to differentiate them have hampered study of the normal expression profile of FcγRIIb and its potential dysregulation in autoimmune diseases such as systemic lupus erythematosus (SLE). Using our newly developed anti-FcγRIIb mAb 4F5 which does not react with FcγRIIa, we found that FcγRIIb is expressed on the cell surface of circulating B lymphocytes, monocytes, neutrophils, myeloid dendritic cells (DCs), and at very low levels on plasmacytoid DCs from some donors. Normal donors with the less frequent 2B.4 promoter haplotype have higher FcγRIIb expression on monocytes, neutrophils, and myeloid DCs similar to that reported for B lymphocytes, indicating that FcγRIIb expression on both myeloid and lymphoid cells is regulated by the naturally occurring regulatory single nucleotide polymorphisms in the FCGR2B promoter. FcγRIIb expression in normal controls is up-regulated on memory B lymphocytes compared with naive B lymphocytes. In contrast, in active SLE, FcγRIIb is significantly down-regulated on both memory and plasma B lymphocytes compared with naive and memory/plasma B lymphocytes from normals. Similar down-regulation of FcγRIIb on myeloid-lineage cells in SLE was not seen. Our studies demonstrate the constitutive regulation of FcγRIIb by natural gene polymorphisms and the acquired dysregulation in SLE autoimmunity, which may identify opportunities for using this receptor as a therapeutic target.

AB - FcγRIIb (CD32B, Online Mendelian Inheritance in Man 604590), an IgG FcR with a tyrosine-based inhibitory motif, plays a critical role in the balance of tolerance and autoimmunnity in murine models. However, the high degree of homology between FcγRIIb and FcγRIIa in humans and the lack of specific Abs to differentiate them have hampered study of the normal expression profile of FcγRIIb and its potential dysregulation in autoimmune diseases such as systemic lupus erythematosus (SLE). Using our newly developed anti-FcγRIIb mAb 4F5 which does not react with FcγRIIa, we found that FcγRIIb is expressed on the cell surface of circulating B lymphocytes, monocytes, neutrophils, myeloid dendritic cells (DCs), and at very low levels on plasmacytoid DCs from some donors. Normal donors with the less frequent 2B.4 promoter haplotype have higher FcγRIIb expression on monocytes, neutrophils, and myeloid DCs similar to that reported for B lymphocytes, indicating that FcγRIIb expression on both myeloid and lymphoid cells is regulated by the naturally occurring regulatory single nucleotide polymorphisms in the FCGR2B promoter. FcγRIIb expression in normal controls is up-regulated on memory B lymphocytes compared with naive B lymphocytes. In contrast, in active SLE, FcγRIIb is significantly down-regulated on both memory and plasma B lymphocytes compared with naive and memory/plasma B lymphocytes from normals. Similar down-regulation of FcγRIIb on myeloid-lineage cells in SLE was not seen. Our studies demonstrate the constitutive regulation of FcγRIIb by natural gene polymorphisms and the acquired dysregulation in SLE autoimmunity, which may identify opportunities for using this receptor as a therapeutic target.

UR - http://www.scopus.com/inward/record.url?scp=33847375266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847375266&partnerID=8YFLogxK

M3 - Article

C2 - 17312177

AN - SCOPUS:33847375266

VL - 178

SP - 3272

EP - 3280

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 5

ER -